diazomethane has been researched along with 1-(indol-4-yloxy)-3-(1-(4-azido-3-iodophenyl)-2-isobutylamine)-2-propanol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ross, EM; Ruoho, AE; Slaughter, C; Wong, SK | 1 |
1 other study(ies) available for diazomethane and 1-(indol-4-yloxy)-3-(1-(4-azido-3-iodophenyl)-2-isobutylamine)-2-propanol
Article | Year |
---|---|
The catecholamine binding site of the beta-adrenergic receptor is formed by juxtaposed membrane-spanning domains.
Topics: Affinity Labels; Animals; Azides; Binding Sites; Catecholamines; Cell Membrane; Diazomethane; Iodocyanopindolol; Peptide Mapping; Photochemistry; Pindolol; Receptors, Adrenergic, beta; Rhodopsin; Turkeys | 1988 |